{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:17:52Z","timestamp":1786994272603,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","award":["44615"],"award-info":[{"award-number":["44615"]}],"id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.modpat.2026.100971","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T07:14:26Z","timestamp":1770016466000},"page":"100971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathologic and Molecular Features of Tubo-Ovarian Carcinosarcomas With an Emphasis on p53 Wild-Type, KRAS-Mutated Tumors"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4206-2002","authenticated-orcid":false,"given":"Phoebe M.","family":"Hammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandra G.","family":"Kingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone A.","family":"Sasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0309-6680","authenticated-orcid":false,"given":"Brooke E.","family":"Howitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.modpat.2026.100971_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/djy071","article-title":"Invasive epithelial ovarian cancer survival by histotype and disease stage","volume":"111","author":"Peres","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.modpat.2026.100971_bib2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.annonc.a059312","article-title":"Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients","volume":"6","author":"Chang","year":"1995","journal-title":"Ann Oncol"},{"issue":"43","key":"10.1016\/j.modpat.2026.100971_bib3","doi-asserted-by":"crossref","first-page":"12238","DOI":"10.1073\/pnas.1614120113","article-title":"Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition","volume":"113","author":"Zhao","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.modpat.2026.100971_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0046-8177(98)90394-X","article-title":"Carcinosarcomas (malignant mixed Mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components","volume":"29","author":"Kounelis","year":"1998","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.100971_bib5","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1038\/s41467-019-12985-x","article-title":"Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma","volume":"10","author":"Gotoh","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.modpat.2026.100971_bib6","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41416-022-01874-8","article-title":"Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma","volume":"127","author":"Hollis","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.modpat.2026.100971_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1038211","article-title":"Epidemiology and prediction model of patients with carcinosarcoma in the United States","volume":"10","author":"Chen","year":"2022","journal-title":"Front Public Health"},{"issue":"7447","key":"10.1016\/j.modpat.2026.100971_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.modpat.2026.100971_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","article-title":"Integrated molecular characterization of uterine carcinosarcoma","volume":"31","author":"Cherniack","year":"2017","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.modpat.2026.100971_bib10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/PAS.0000000000002250","article-title":"Molecular classification outperforms histologic classification in prognostication of high-grade endometrial carcinomas with undifferentiated and sarcomatous components","volume":"48","author":"Hammer","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.100971_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100676","article-title":"POLE-mutated uterine carcinosarcomas: a clinicopathologic and molecular study of 11 cases","volume":"38","author":"Hammer","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.100971_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1408196","article-title":"Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomes","volume":"14","author":"Dhillon","year":"2024","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2026.100971_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264138","article-title":"Clinical and analytical validation of FoundationOne\u00aeCDx, a comprehensive genomic profiling assay for solid tumors","volume":"17","author":"Milbury","year":"2022","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.modpat.2026.100971_bib14","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41379-021-00963-y","article-title":"Prospective molecular classification of endometrial carcinomas: institutional implementation, practice, and clinical experience","volume":"35","author":"Devereaux","year":"2022","journal-title":"Mod Pathol"},{"issue":"24","key":"10.1016\/j.modpat.2026.100971_bib15","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.18632\/oncotarget.26797","article-title":"Clinical validation of the tempus xT next-generation targeted oncology sequencing assay","volume":"10","author":"Beaubier","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.modpat.2026.100971_bib16","series-title":"Female Genital Tumours","year":"2020"},{"issue":"1","key":"10.1016\/j.modpat.2026.100971_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/his.14015","article-title":"Incorporation of molecular characteristics into endometrial cancer management","volume":"76","author":"Vermij","year":"2020","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.modpat.2026.100971_bib18","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2026.100971_bib19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.5373","article-title":"Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.100971_bib20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00428-024-03821-9","article-title":"Molecular characteristics of tubo-ovarian carcinosarcoma at different anatomic locations","volume":"485","author":"Davidson","year":"2024","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.modpat.2026.100971_bib21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","article-title":"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas","volume":"20","author":"Pennington","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.modpat.2026.100971_bib22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/modpathol.2011.208","article-title":"Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing","volume":"25","author":"Djordjevic","year":"2012","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.100971_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100106","article-title":"PTEN deficiency in tubo-ovarian high-grade serous carcinoma is associated with poor progression-free survival and is mutually exclusive with CCNE1 amplification","volume":"36","author":"Zhang","year":"2023","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.100971_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract","volume":"42","author":"Mirkovic","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"14","key":"10.1016\/j.modpat.2026.100971_bib25","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1158\/1078-0432.CCR-23-2819","article-title":"Clinical and genomic landscape of RAS mutations in gynecologic cancers","volume":"30","author":"Son","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"7968","key":"10.1016\/j.modpat.2026.100971_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","article-title":"Pan-KRAS inhibitor disables oncogenic signalling and tumour growth","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.modpat.2026.100971_bib27","doi-asserted-by":"crossref","first-page":"15727","DOI":"10.1007\/s00432-023-05306-9","article-title":"Mesonephric-like adenocarcinoma of the female genital tract: possible role of KRAS-targeted treatment-detailed molecular analysis of a case series and review of the literature for targetable somatic KRAS-mutations","volume":"149","author":"Brambs","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.100971_bib28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ygyno.2010.11.039","article-title":"Tissue-specific signatures of activating PIK3CA and RAS mutations in carcinosarcomas of gynecologic origin","volume":"121","author":"Growdon","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.modpat.2026.100971_bib29","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/his.14892","article-title":"Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas","volume":"82","author":"Mirkovic","year":"2023","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.modpat.2026.100971_bib30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.21873\/cgp.20357","article-title":"Mesonephric-like carcinosarcoma of the uterine corpus: clinicopathological, molecular and prognostic characteristics in comparison with uterine mesonephric-like adenocarcinoma and conventional endometrial carcinosarcoma","volume":"19","author":"Park","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"issue":"5","key":"10.1016\/j.modpat.2026.100971_bib31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/PAS.0000000000002368","article-title":"Clinicopathologic and molecular characterization of gynecologic carcinosarcomas with a mesonephric-like carcinomatous component","volume":"49","author":"Mendoza","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.100971_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/PGP.0000000000000991","article-title":"Ovarian mesonephric-like adenocarcinoma recurring with a rhabdomyosarcoma component: a case report","volume":"43","author":"Yamamoto","year":"2024","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.modpat.2026.100971_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2024.09.008","article-title":"Concurrent POLE hotspot mutations and mismatch repair deficiency\/microsatellite instability in endometrial cancer: a challenge in molecular classification","volume":"191","author":"Moufarrij","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2026.100971_bib34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/PAS.0000000000002165","article-title":"Specific pathology features enrich selection of endometrial carcinomas for POLE testing","volume":"48","author":"Keyhanian","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.100971_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13053-021-00185-y","article-title":"A novel germline mutation in hMLH1 in three Korean women with endometrial cancer in a family of Lynch syndrome: case report and literature review","volume":"19","author":"Jung","year":"2021","journal-title":"Hered Cancer Clin Pract"},{"issue":"1","key":"10.1016\/j.modpat.2026.100971_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/PGP.0000000000000290","article-title":"Two cases of carcinosarcomas of the ovary involved in hereditary cancer syndromes","volume":"36","author":"Carnevali","year":"2017","journal-title":"Int J Gynecol Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:34:21Z","timestamp":1782128061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0893395226000141"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.100971","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic and Molecular Features of Tubo-Ovarian Carcinosarcomas With an Emphasis on p53 Wild-Type, KRAS-Mutated Tumors","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.100971","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100971"}}